Jacob A. Orville, EVP, GM, Screening at EXACT SCIENCES CORP (EXAS), sold 5,000 shares at $75.00 ($375K) on 2025-11-19, disclosed to the SEC on 2025-11-21.
Scheduled sale ($375k) by EVP, GM, Screening under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| EXAS | SELL | 2024-02-28 | $214K | — | Filing → |
| EXAS | SELL | 2024-02-23 | $121K | — | Filing → |
| EXAS | SELL | 2024-02-22 | $66K | — | Filing → |